BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21558398)

  • 1. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer.
    Lin BR; Chang CC; Chen RJ; Jeng YM; Liang JT; Lee PH; Chang KJ; Kuo ML
    Clin Cancer Res; 2011 May; 17(10):3077-88. PubMed ID: 21558398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of PITX2 overexpression in human colorectal cancer.
    Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin α3β1-dependent adhesion.
    Chen CN; Chang CC; Lai HS; Jeng YM; Chen CI; Chang KJ; Lee PH; Lee H
    Gastric Cancer; 2015 Jul; 18(3):504-15. PubMed ID: 24985492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
    Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
    Mino K; Ozaki M; Nakanishi K; Haga S; Sato M; Kina M; Takahashi M; Takahashi N; Kataoka A; Yanagihara K; Ochiya T; Kamiyama T; Umezawa K; Todo S
    Cancer Sci; 2011 May; 102(5):1052-8. PubMed ID: 21288284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB7 as a prognostic factor and mediator of colorectal cancer progression.
    Liao WT; Jiang D; Yuan J; Cui YM; Shi XW; Chen CM; Bian XW; Deng YJ; Ding YQ
    Clin Cancer Res; 2011 Jun; 17(11):3569-78. PubMed ID: 21474578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
    Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors.
    Yasui N; Sakamoto M; Ochiai A; Ino Y; Akimoto S; Orikasa A; Kitajima M; Hirohashi S
    Invasion Metastasis; 1997; 17(5):259-69. PubMed ID: 9876220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
    Yokoe T; Toiyama Y; Okugawa Y; Tanaka K; Ohi M; Inoue Y; Mohri Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2010 Mar; 17(3):821-8. PubMed ID: 19898899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prognosis of synchronous colorectal carcinomatosis.
    Goéré D; Allard MA; Honoré C; Dumont F; Elias D
    Future Oncol; 2013 Apr; 9(4):541-9. PubMed ID: 23560376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.
    Lin BR; Chang CC; Che TF; Chen ST; Chen RJ; Yang CY; Jeng YM; Liang JT; Lee PH; Chang KJ; Chau YP; Kuo ML
    Gastroenterology; 2005 Jan; 128(1):9-23. PubMed ID: 15633118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.